Medicamen Biotech files ANDA for Bortezomib for injection with USFDA Ruchika Sharma19 July 2023 4:18 PM ISTNew Delhi: Medicamen Biotech Limited has announced that the company has successfully filed the first ANDA in eCTD format for BORTEZOMIB for...
Baby powder suit: Johnson and Johnson must pay USD 18.8 million to California cancer patient Ruchika Sharma19 July 2023 3:57 PM ISTJohnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided...
JnJ sues in latest bid to halt Medicare drug price negotiations Ruchika Sharma19 July 2023 3:41 PM ISTJohnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government...
Eli Lilly presents results from Phase 3 trial of Donanemab at Alzheimer's Association Conference Ruchika Sharma19 July 2023 12:39 PM ISTIndianapolis: Eli Lilly and Company has presented full results from the Phase 3 TRAILBLAZER-ALZ 2 study showing that donanemab significantly...
Pfizer, Flagship Pioneering partner to create new pipeline of innovative medicines Ruchika Sharma19 July 2023 12:00 PM ISTCambridge: Flagship Pioneering, Inc. and Pfizer Inc. have announced the companies have partnered to create a new pipeline of innovative medicines....
Piramal Pharma gets SEBI go ahead to raise up to Rs 1050 crore through rights issue Ruchika Sharma18 July 2023 3:30 PM ISTProceeds of the issue will be utilised for payment of debt and general corporate purposes.
Compugen wins on PVRIG European patent opposition pursued by GSK, a third party Ruchika Sharma18 July 2023 2:39 PM ISTHolon: Compugen Ltd., a clinical-stage cancer immunotherapy company has announced that the broad claims of Compugen's Anti-PVRIG Antibodies...
Phase 3 trial of Rybrevant plus chemotherapy in lung cancer meets primary endpoint: Janssen Ruchika Sharma18 July 2023 1:30 PM ISTNew Jersey: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the Phase 3 PAPILLON study ...
Novartis acquires DTx Pharma for USD 500 million plus milestone payments Ruchika Sharma18 July 2023 12:30 PM ISTThe agreement underscores the Novartis commitment to Neuroscience, one of the company's five core therapeutic areas, and to pursuing innovative...
Sanofi-AstraZeneca Beyfortus gets USFDA nod for protection of infants against RSV disease Ruchika Sharma18 July 2023 11:24 AM ISTParis: The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab-alip) for the prevention of...
Submit the PSUR data: CDSCO Tells Hetero Biopharma on Phase IV CT protocol of Tenecteplase Lyophilized powder for injection Dr. Divya Colin17 July 2023 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
Submit additional data: CDSCO Tells Laurus Labs to on Carglumic acid dispersible tablets Dr. Divya Colin17 July 2023 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has recommended the drug major...
